Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Moll

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Plos One|April 30, 2021
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort studyNancy Perrottet, Mario Fernández-Ruiz, Isabelle Binet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2023
Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney diseaseAnna Faivre, Romain Dissard, Willy Kuo, et al.
Journal of Translational Medicine|June 3, 2018
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regimeSolange Moll, Yukari Yasui, Ahmed Abed, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2009
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)Agnes B Fogo, Leif Bostad, Einar Svarstad, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2022
Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney DiseaseThomas Verissimo, Anna Faivre, Anna Rinaldi, et al.
Kidney International|July 11, 2025
Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progressionDelal Dalga, Anna Rinaldi, Xiaorong Fu, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes ComplicationsSanthosh Kumar Vr, Murthy N Darisipudi, Stefanie Steiger, et al.
ACS Chemical Biology|November 20, 2018
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport SyndromeHans Richter, Alexander L Satz, Marc Bedoucha, et al.
Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Plos One|April 30, 2021
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort studyNancy Perrottet, Mario Fernández-Ruiz, Isabelle Binet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2023
Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney diseaseAnna Faivre, Romain Dissard, Willy Kuo, et al.
Journal of Translational Medicine|June 3, 2018
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regimeSolange Moll, Yukari Yasui, Ahmed Abed, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2009
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)Agnes B Fogo, Leif Bostad, Einar Svarstad, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2022
Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney DiseaseThomas Verissimo, Anna Faivre, Anna Rinaldi, et al.
Kidney International|July 11, 2025
Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progressionDelal Dalga, Anna Rinaldi, Xiaorong Fu, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes ComplicationsSanthosh Kumar Vr, Murthy N Darisipudi, Stefanie Steiger, et al.
ACS Chemical Biology|November 20, 2018
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport SyndromeHans Richter, Alexander L Satz, Marc Bedoucha, et al.
Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Pageof 9